K0I

3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid

Created:	2012-05-01
Last modified:	2021-03-13

Find Related PDB Entry
5 entries where K0I is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	0
Bond Count	55
Aromatic Bond Count	18

2D diagram of K0I

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid
Synonyms	3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid
Systematic Name (OpenEye OEToolkits)	3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid
Formula	C₂₂ H₂₃ N₅ O₂
Molecular Weight	389.45
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)CCNc2nc(c1ncccc1)nc(c2)N3CCc4c(CC3)cccc4
SMILES	CACTVS	3.385	OC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3
SMILES	OpenEye OEToolkits	1.7.6	c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4ccccn4)NCCC(=O)O
Canonical SMILES	CACTVS	3.385	OC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4ccccn4)NCCC(=O)O
InChI	InChI	1.03	InChI=1S/C22H23N5O2/c28-21(29)8-12-24-19-15-20(26-22(25-19)18-7-3-4-11-23-18)27-13-9-16-5-1-2-6-17(16)10-14-27/h1-7,11,15H,8-10,12-14H2,(H,28,29)(H,24,25,26)
InChIKey	InChI	1.03	AVZCPICCWKMZDT-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3188597
PubChem	56963315
ChEMBL	CHEMBL3188597
ChEBI	CHEBI:131152

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.